MEDAREX GETS MILESTONE PAYMENTMedarex Inc. of Princeton, N.J., said it has received a $250,000milestone payment from Centre National de TransfusionSanguine (CNTS), the French national center for bloodtransfusion.

The payment brings total payments to date from CNTS to $2.25million. The funding is part of a 1989 agreement to collaborateon AIDS and cancer treatments under which Medarex willreceive $3.2 million and sales royalties. CNTS will haveEuropean rights to certain Medarex therapeutics that may bedeveloped using its bispecific antibody technology.

Medarex (NASDAQ:MEDX and MEDXW) completed its initial publicoffering in June.


Quintiles Transnational Corp., a contract research companybased in Research Triangle Park, N.C., said it has raised $5million in a private placement of its common stock. Investorswere Thompson Clive & Partners Ltd. and NCNB Venture Co. L.P.The company has research centers in the United States, Japan,the United Kingdom, Ireland and Germany.

(c) 1997 American Health Consultants. All rights reserved.